Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Shen

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
Annals of Surgical Oncology|March 7, 2003
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisRichard P McQuellon, Brian W Loggie, Anna B Lehman, et al.
Journal of Surgical Oncology|September 28, 2018
Analysis of recurrence after the resection of pancreatic neuroendocrine tumorsKonstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, et al.
Annals of Surgical Oncology|August 15, 2022
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Annals of Surgical Oncology|December 5, 2024
ASO Visual Abstract: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Annals of Surgical Oncology|October 27, 2023
Quality-of-Life Outcomes for Patients Taking Opioids and Psychotropic Medications Before Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyIan Solsky, Ana Patel, Cristian D Valenzuela, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosisPerry Shen, Edward A Levine, Jason Hall, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancerJason J Hall, Brian W Loggie, Perry Shen, et al.
Annals of Surgical Oncology|November 12, 2024
Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Langenbeck'S Archives of Surgery|June 17, 2023
Risk factors and outcomes for cholangitis after hepatic resectionChristopher W Mangieri, Matthew A Strode, Omeed Moaven, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
Annals of Surgical Oncology|March 7, 2003
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosisRichard P McQuellon, Brian W Loggie, Anna B Lehman, et al.
Journal of Surgical Oncology|September 28, 2018
Analysis of recurrence after the resection of pancreatic neuroendocrine tumorsKonstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, et al.
Annals of Surgical Oncology|August 15, 2022
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky, et al.
Annals of Surgical Oncology|December 5, 2024
ASO Visual Abstract: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Annals of Surgical Oncology|October 27, 2023
Quality-of-Life Outcomes for Patients Taking Opioids and Psychotropic Medications Before Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyIan Solsky, Ana Patel, Cristian D Valenzuela, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosisPerry Shen, Edward A Levine, Jason Hall, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancerJason J Hall, Brian W Loggie, Perry Shen, et al.
Annals of Surgical Oncology|November 12, 2024
Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal DisseminationEdward A Levine, Heidy Cos, Konstantinos I Votanopoulos, et al.
Langenbeck'S Archives of Surgery|June 17, 2023
Risk factors and outcomes for cholangitis after hepatic resectionChristopher W Mangieri, Matthew A Strode, Omeed Moaven, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Pageof 26